Get the Stockscreener App
2.69
1.89%
0.05
After Hours:
2.79
0.10
+3.72%
Quanterix Corp stock is traded at $2.69, with a volume of 814.98K.
It is up +1.89% in the last 24 hours and down -17.48% over the past month.
Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.
See More
Previous Close:
$2.64
Open:
$2.64
24h Volume:
814.98K
Relative Volume:
0.78
Market Cap:
$126.72M
Revenue:
$138.90M
Net Income/Loss:
$-107.15M
P/E Ratio:
-1.0661
EPS:
-2.5232
Net Cash Flow:
$-79.85M
1W Performance:
-2.18%
1M Performance:
-17.48%
6M Performance:
-59.61%
1Y Performance:
-44.31%
1-Day Range:
$2.61
$2.80
1-Week Range:
$2.395
$2.83
52-Week Range:
$2.395
$8.77
Quanterix Corp Stock (QTRX) Company Profile
Name
Quanterix Corp
Sector
Industry
Phone
617-301-9400
Address
900 MIDDLESEX TURNPIKE, BILLERICA, MA
Compare QTRX vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
QTRX
Quanterix Corp
|
2.69 | 124.36M | 138.90M | -107.15M | -79.85M | -2.5232 |
ABT
Abbott Laboratories
|
87.41 | 152.88B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
316.48 | 120.18B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.60 | 100.34B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.78 | 84.95B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.78 | 47.91B | 6.30B | 1.07B | 1.09B | 1.8406 |
Quanterix Corp Stock (QTRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-11-25 | Downgrade | Canaccord Genuity | Buy → Hold |
| Feb-01-24 | Initiated | Scotiabank | Sector Outperform |
| Sep-25-23 | Upgrade | Canaccord Genuity | Hold → Buy |
| Aug-08-23 | Upgrade | SVB Securities | Market Perform → Outperform |
| May-23-23 | Upgrade | Goldman | Neutral → Buy |
| Aug-15-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Aug-09-22 | Downgrade | Cowen | Outperform → Market Perform |
| Aug-09-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Mar-02-22 | Upgrade | Goldman | Sell → Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Jun-04-21 | Initiated | Goldman | Sell |
View All
Quanterix Corp Stock (QTRX) Latest News
Quanterix targets $169M-$174M 2026 revenue while preparing HD-X IVD filing in 2027 - MSN
Quanterix (QTRX) CFO reports RSU vesting and tax-withholding share dispositions - Stock Titan
Quanterix (QTRX) CTO gains 1,558 shares from RSU vesting, 467 withheld for tax - Stock Titan
Quanterix Corp stock (US74876Y1001): Analyst price target raised while shares trade near lows - AD HOC NEWS
Portolan Capital, George McCabe report 6.25% stake in Quanterix (QTRX) - Stock Titan
Quanterix (NASDAQ: QTRX) — Ameriprise reports 3,542,374 shared votes - Stock Titan
QTRX Technical Analysis | Trend, Signals & Chart Patterns | QUANTERIX CORP (NASDAQ:QTRX) - ChartMill
Quanterix stock (US74876Y1001): Biotech diagnostics firm faces headwinds amid guidance revision - AD HOC NEWS
AMERIPRISE FINANCIAL INC Significantly Reduces Stake in Quanteri - GuruFocus
Quanterix (QTRX) Announces CFO Departure and Transition Plans - GuruFocus
Quanterix CFO Vandana Sriram to depart in June - Investing.com
Quanterix CFO Michael J. Doyle to Depart on July 3, 2026; Search for Successor Begins - geneonline.com
Quanterix (QTRX) CFO Vandana Sriram to depart in June 2026 after planned transition - Stock Titan
Quanterix finance chief to depart after June 15 handover - Stock Titan
TradingKey - TradingKey
MSN Money - MSN
Quanterix (NASDAQ:QTRX) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Quanterix Corporation (NASDAQ:QTRX) Q1 2026 Earnings Call Transcript - Insider Monkey
QTRX Maintained by TD Cowen -- Price Target Lowered to $4.00 - GuruFocus
Q1 2026 Quanterix Corp Earnings Call Transcript - GuruFocus
Earnings call transcript: Quanterix Q1 2026 EPS beats, revenue misses By Investing.com - Investing.com India
Quanterix Corporation 2026 Q1 Financials: Akoya Acquisition, Revenue Performance & Forward-Looking Statements - Minichart
Quanterix CEO Everett Cunningham Highlights Market Leadership in Earnings Call - HarianBasis.co
Ameriprise Financial (NASDAQ: QTRX) reports 990,224 shares, 2.1% stake - Stock Titan
Quanterix Q1 Earnings Call Highlights - Yahoo Finance
Quanterix Q1 2026 slides: $85M synergies offset organic decline - Investing.com
Quanterix Corporation (QTRX) Reports Q1 Loss, Lags Revenue Estimates - Yahoo! Finance Canada
Earnings call transcript: Quanterix Q1 2026 EPS beats, revenue misses - Investing.com
Quanterix (NASDAQ:QTRX) Beats Q1 2026 EPS Estimates Despite Revenue Miss - ChartMill
Quanterix (NASDAQ: QTRX) grows revenue 20% but books $19.3M impairment - Stock Titan
QUANTERIX ($QTRX) Releases Q1 2026 Earnings, Stock Rises - Quiver Quantitative
Quanterix (NASDAQ: QTRX) grows Q1 revenue 20% and keeps 2026 outlook - Stock Titan
Quanterix keeps 2026 outlook, eyes FDA decision on Alzheimer’s test - Stock Titan
Quanterix partners with Tempus AI on Alzheimer’s blood test - Investing.com
Quanterix Corp expected to post a loss of 54 cents a shareEarnings Preview - TradingView
How The Quanterix (QTRX) Story Is Shifting After The Latest Fair Value Reset - Yahoo Finance
Quanterix (QTRX) COO logs RSU conversion and small tax share disposal - Stock Titan
Quanterix rises on CMS price for LucentAD Alzheimer blood biomarker test - MSN
Quanterix (QTRX) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat
Quanterix (QTRX) price target decreased by 13.33% to 6.63 - MSN
Quanterix schedules after-close Q1 results, 4:30 p.m. ET call - Stock Titan
[ARS] Quanterix Corp SEC Filing - Stock Titan
Quanterix (NASDAQ: QTRX) details 2026 virtual meeting and pay votes - Stock Titan
Quanterix Corp Stock (QTRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.22%
1.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):